2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance(1)

por Gangjee, Aleem, Namjoshi, Ojas A., Keller, Staci N., Smith, Charles D.
Publicado 2011

Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression

por Schrecengost, Randy S., Keller, Staci N., Schiewer, Matthew J., Knudsen, Karen E., Smith, Charles D.
Publicado en Mol Cancer Res (2015)

In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183

por Schrecengost, Randy S., Green, Cecelia L., Zhuang, Yan, Keller, Staci N., Smith, Ryan A., Maines, Lynn W., Smith, Charles D.
Publicado en J Pharmacol Exp Ther (2018)

Suppression of Ulcerative Colitis in Mice by Orally-Available Inhibitors of Sphingosine Kinase

por Maines, Lynn W., Fitzpatrick, Leo R., French, Kevin J., Zhuang, Yan, Xia, Zuping, Keller, Staci N., Upson, John J., Smith, Charles D.
Publicado 2007

Discovery and characterization of inhibitors of human palmitoyl acyltransferases

por Ducker, Charles E., Griffel, Lindsay K., Smith, Ryan A., Keller, Staci N., Zhuang, Yan, Xia, Zuping, Diller, John D., Smith, Charles D.
Publicado 2006

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

por French, Kevin J., Zhuang, Yan, Maines, Lynn W., Gao, Peng, Wang, Wenxue, Beljanski, Vladimir, Upson, John J., Green, Cecelia L., Keller, Staci N., Smith, Charles D.
Publicado 2010